Publicaciones en las que colabora con Javier Cortés Castán (11)

2005

  1. Role of von Willebrand factor levels in the prognosis of stage IV colorectal cancer: Do we have enough evidence?

    World Journal of Gastroenterology

2004

  1. Paclitaxel, cisplatin, and vinorelbine combination chemotherapy in metastatic non-small-cell lung cancer

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 27, Núm. 3, pp. 299-303

2003

  1. Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer

    Oncology, Vol. 64, Núm. 1, pp. 28-35

  2. [18F]-FDG PET and localized fibrous mesothelioma

    Lung, Vol. 181, Núm. 1, pp. 49-54

2002

  1. Combined irinotecan, oxaliplatin and 5-fluorouracil in patients with advanced colorectal cancer: A feasibility pilot study

    Oncology, Vol. 63, Núm. 3, pp. 254-265

  2. Comparison of unidimensional and bidimensional measurements in metastatic non-small cell lung cancer

    British Journal of Cancer, Vol. 87, Núm. 2, pp. 158-160

  3. Docetaxel plus vinorelbine as salvage chemotherapy in advanced breast cancer: A phase II study

    Breast Cancer Research and Treatment, Vol. 76, Núm. 1, pp. 47-56

  4. Irinotecan, oxaliplatin, and 5-fluorouracil/leucovorin combination chemotherapy in advanced colorectal carcinoma: A phase II study

    Clinical Colorectal Cancer, Vol. 2, Núm. 2, pp. 104-110

2001

  1. Adjuvant chemotherapy for completely resected non-small-cell lung cancer [3] (multiple letters)

    New England Journal of Medicine

  2. Fixed higher dose schedule of suramin plus hydrocortisone in patients with hormone refractory prostate carcinoma: A multicenter phase II study

    Cancer, Vol. 92, Núm. 9, pp. 2435-2443

2000

  1. Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma: A phase II study

    Cancer, Vol. 89, Núm. 12, pp. 2622-2629